论文部分内容阅读
目的:探讨糖尿病合并肺结核患者的临床治疗方法。方法:选取我院自2010年1月至2012年1月间收治的124例2型糖尿病合并肺结核患者进行分析研究,随机分为2组,每组62例,对照组患者采用口服降糖药进行治疗,观察组患者采用胰岛素皮下注射进行治疗,比较两组患者临床治疗效果。结果:观察组患者的在治疗6个月和18个月后,其转阴率明显高于对照组(P<0.05);且观察组患者治疗后,其空洞闭合率也明显高于对照组,P<0.05,具有统计学意义。观察组患者治疗总有效率达到93.55%,对照组患者治疗总有效率为69.35%,观察组患者临床治疗效果明显优于对照组,P<0.05,具有统计学意义。结论:采用胰岛素皮下注射方式进行糖尿病合并肺结核患者的治疗,可以有效改善患者临床症状,减轻患者痛苦,安全、有效,值得临床推广应用。
Objective: To investigate the clinical treatment of diabetic patients with pulmonary tuberculosis. Methods: A total of 124 patients with type 2 diabetes mellitus and pulmonary tuberculosis admitted to our hospital from January 2010 to January 2012 were randomly divided into 2 groups (n = 62 each). Patients in the control group were treated with oral hypoglycemic agents The patients in observation and treatment groups were treated with subcutaneous injection of insulin, and the clinical effects of two groups were compared. Results: After 6 months and 18 months of treatment, the rate of negative conversion in observation group was significantly higher than that in control group (P <0.05). After treatment, the void closure rate in observation group was also significantly higher than that in control group P <0.05, with statistical significance. The total effective rate of observation group patients reached 93.55%, the total effective rate of the control group was 69.35%, the clinical efficacy of observation group was significantly better than the control group, P <0.05, with statistical significance. Conclusion: The subcutaneous injection of insulin for the treatment of diabetic patients with pulmonary tuberculosis can effectively improve the clinical symptoms of patients, reduce the pain, safety and effectiveness of patients, worthy of clinical application.